Ad is loading...
MENU

GLUE Monte Rosa Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
GLUE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
GLUE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

GLUE is expected to report earnings to rise 53.86% to -44 cents per share on March 13

Monte Rosa Therapeutics GLUE Stock Earnings Reports
Q4'24
Est.
$-0.45
Q3'24
Beat
by $0.18
Q2'24
Beat
by $0.09
Q1'24
Beat
by $0.06
Q4'23
Missed
by $0.19
The last earnings report on November 07 showed earnings per share of -28 cents, beating the estimate of -46 cents. With 661.79K shares outstanding, the current market capitalization sits at 605.77M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 949-2643
Employees
133
Web
https://www.monterosatx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIATX30.110.22
+0.74%
Fidelity Advisor Intl Cap App M
TROCX27.640.16
+0.58%
Touchstone Non-US ESG Equity I
MRBVX18.15N/A
N/A
BlackRock Large Cap Focus Value R
RINCX18.44N/A
N/A
Victory RS Science and Technology C
RSRFX10.79-0.07
-0.64%
Reaves Infrastructure Fund Class Inst

GLUE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with RXRX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-3.52%
RXRX - GLUE
49%
Loosely correlated
-6.46%
MDGL - GLUE
47%
Loosely correlated
+0.88%
PRTA - GLUE
43%
Loosely correlated
-8.13%
BEAM - GLUE
41%
Loosely correlated
-8.18%
RCKT - GLUE
40%
Loosely correlated
-6.32%
More